Account
Articles

High Pharma margins increasing the squeeze on health systems

22/02/2019

Read the article here which focusses on the cost of cancer treatment versus their manufacturing costs.

Author:

Graham Foxon, PhD, MBA
About the Author

Article Tags

Oncology Pricing

Share this article

Related articles

Articles
01.10.2025
MFN Drug Pricing Proposal: What It Could Mean for ...

Negotiations between the Trump administration and pharmaceutical companies on lowering U.S...

Read more
Articles
29.09.2025
Your 5-step ATMP pricing playbook for launch succe...

Advanced Therapy Medicinal Products (ATMPs) are offering transformative, and often life-saving, trea...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch